TP53 and nonpapillary renal cell carcinoma: Even though rarely-occurring mutations of TP53 have been linked to poor prognosis in ccRCC [77] and its overexpression in ccRCC has not shown any real clinical potential [78], its elevated expression is under-reported and demands further study.